1.
Acta Pharmaceutica Sinica B
;
(6): 4032-4044, 2021.
Artigo
em Inglês
| WPRIM
| ID: wpr-922458
RESUMO
Insurmountable blood‒brain barrier (BBB) and complex pathological features are the key factors affecting the treatment of Alzheimer's disease (AD). Poor accumulation of drugs in lesion sites and undesired effectiveness of simply reducing A